Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

The Rise Fund

Founders Michael R. Stone

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 63
Average round size
info
The average size of a deal this fund participated in
$107M
Portfolio companies 44
Rounds per year 7.88
Lead investments 20
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 5
Key employees Soon

Areas of investment

  • Financial Services
  • Health Care
  • FinTech
  • Therapeutics
  • Education
Summary

The Rise Fund appeared to be the VC, which was created in 2016.

The top activity for fund was in 2018. The increased amount of exits for fund were in 2019. The fund is generally included in 7-12 deals every year. The usual things for fund are deals in the range of 50 - 100 millions dollars. Considering the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this The Rise Fund works on 24 percentage points less the average amount of lead investments. The average startup value when the investment from The Rise Fund is more than 1 billion dollars.

The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight C3 IoT, EVERFI, Zipline. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are FinTech, Therapeutics.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the The Rise Fund, startups are often financed by e.ventures, TomorrowVentures, Sound Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Growth, Velocity Capital & Progression Africa, Endeavor Catalyst. In the next rounds fund is usually obtained by e.ventures, Warburg Pincus, Torch Capital.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of The Rise Fund:
Typical Co-investors
The Rise Fund is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after The Rise Fund:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerated Innovation Stockholm, Stockholm County, Sweden
Archer Gray New York, New York, United States
Brobeck, Phleger & Harrison -
Climb Ventures Geneva, Geneve, Switzerland
D64 Ventures -
DAYLI Financial Group Seoul, Seoul-t'ukpyolsi, South Korea
Decent Capital China, Guangdong, Shenzhen
Diamond Management and Technology Consultants Chicago, Illinois, United States
EJF Capital Arlington, United States, Virginia
Hangzhou Dongfang Jiafu Asset Management Co. China, Hangzhou, Zhejiang
Innvotec England, London, United Kingdom
Nordic Bioscience Denmark, Herlev, Hovedstaden
NRMA Australia, New South Wales, Sydney
Origins Capital Beijing, Beijing Shi, China
PagerDuty California, San Francisco, United States
Partam Tel A Viv Israel, Tel Aviv, Tel Aviv District
Prasetia Dwidharma Indonesia, Jakarta Pusat, Jakarta Raya
SBI Insurance Group -
Sony Startup Acceleration Program Lund, Skane Lan, Sweden

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Sionna Therapeutics

Genetics
Health Care
Medical
Pharmaceutical
Therapeutics
$182M06 Mar 2024 Natick, Massachusetts, United States

Bicara Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$165M12 Dec 2023 Cambridge, Massachusetts, United States

Little Leaf Farms

Farming
$300M15 Jun 2022 Devens, Massachusetts, United States

Sling Therapeutics

Biopharma
Biotechnology
$35M13 Jun 2022 Ann Arbor, Michigan, United States

Persefoni

Analytics
Artificial Intelligence
CleanTech
Enterprise Software
GreenTech
SaaS
Social Impact
Sustainability
$101M28 Oct 2021 Tempe, Arizona, United States

Climavision

Artificial Intelligence
Digital Media
Internet
News
$100M02 Jun 2021 Louisville, Kentucky, United States

Ceribell

Biotechnology
Health Care
Health Diagnostics
Medical Device
$102M29 Apr 2021 Mountain View, California, United States

Nithio Holdings

Energy
Environmental Engineering
Finance
Renewable Energy
Solar
$30M15 Apr 2021 Washington, District of Columbia, United States

Rad Power Bikes

CleanTech
Consumer Goods
Electric Vehicle
Manufacturing
Transportation
$150M04 Feb 2021 Seattle, Washington, United States
News
Human Interest raises $200M at a $1B valuation, plans for an IPO

– SMB 401(k) provider Human Interest raised $200m in a round of funding.
– The round was led by Rise Fund and joined by SoftBank Vision Fund 2.
– The financing included participation from new investor Crosslink Capital and existing backers.
– The company has now raised a total of $336.7m since its 2015 inception.
– It plans to IPO in 2023.

Climavision Raises $100M in Funding

– Climavision, a Louisville, Ky.-based provider of a weather services and intelligence platform, raised $100m in funding.
The Rise Fund made the investment.
– As part of the transaction, TPG’s Edward Beckley, Steven Mandel, and Mariana Popa, who make climate investments on behalf of the Rise platform, will join Climavision’s board of directors alongside Chris Goode and Co-Founder Colin Cookes.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent The Rise Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 63
Average round size 107M
Rounds per year 7.88
Peak activity year 2018
Lead investments 20
Follow on index 0.29
Exits 5
Group Appearance index 0.84

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Sionna Therapeutics

Genetics
Health Care
Medical
Pharmaceutical
Therapeutics
$182M06 Mar 2024 Natick, Massachusetts, United States

Bicara Therapeutics

Biopharma
Biotechnology
Health Care
Life Science
Therapeutics
$165M12 Dec 2023 Cambridge, Massachusetts, United States

Little Leaf Farms

Farming
$300M15 Jun 2022 Devens, Massachusetts, United States

Sling Therapeutics

Biopharma
Biotechnology
$35M13 Jun 2022 Ann Arbor, Michigan, United States

Persefoni

Analytics
Artificial Intelligence
CleanTech
Enterprise Software
GreenTech
SaaS
Social Impact
Sustainability
$101M28 Oct 2021 Tempe, Arizona, United States

Climavision

Artificial Intelligence
Digital Media
Internet
News
$100M02 Jun 2021 Louisville, Kentucky, United States

Ceribell

Biotechnology
Health Care
Health Diagnostics
Medical Device
$102M29 Apr 2021 Mountain View, California, United States

Nithio Holdings

Energy
Environmental Engineering
Finance
Renewable Energy
Solar
$30M15 Apr 2021 Washington, District of Columbia, United States

Rad Power Bikes

CleanTech
Consumer Goods
Electric Vehicle
Manufacturing
Transportation
$150M04 Feb 2021 Seattle, Washington, United States
Crunchbase icon

Content report

The following text will be sent to our editors: